Hanu Tyagi

Hanu Tyagi

PhD Student
Supply Chain & Operations

Education:

  • Bachelor of Technology 2008
    Mechanical Engineering, National Institute of Technology, Warangal (India)
  • Post-Graduate Programme in Management 2013
    Management, Indian School of Business, Hyderabad (India)
  • Ph.D. (Ongoing)
    Supply Chain and Operations, Carlson School of Management, University of Minnesota - Twin Cities

Expertise:

  • New product development
  • Innovation
  • Shortages
  • Supply chain transparency

Biography

I am a fourth-year Ph.D. candidate in the Supply Chain and Operations department at the Carlson School of Management, University of Minnesota. I am interested in studying how operational decisions affect the development and distribution of pharmaceutical drugs. My questions explore themes such as supply chain transparency, innovation, new product development, and shortages. I use a mix of empirical and experimental research methodologies and theory-driven frameworks to answer my research questions.

  • Under the drug development stream, I explore 
    • How expedited new product development leads to issues in drug quality?
    • How transparency in new product development impacts drug innovation? 
  • Under the drug distribution stream, I examine 
    • How transparency in the supply chain impacts shortages?
    • How does quality failure spill over?
    • How inventory transparency affects panic buying?

Before joining the Ph.D. program, I worked as a Research Associate at the Indian School of Business, Hyderabad (India) with Professor Sarang Deo. Before entering academia, I worked as a management consultant at EY-Parthenon (Dubai, UAE) and ZS Associates (Pune, India). I also worked in the management trainee program at Ranbaxy Labs. Ltd (Gurgaon, India). I have a Post-Graduate Programme in Management from the Indian School of Business, Hyderabad (India), and a Bachelor of Technology from the National Institute of Technology, Warangal (India)

On the personal front, I am a traveler, a hiking/trekking enthusiast, and an open-water scuba diver. I am also an avid music lover who is learning Hindustani classical singing.

Selected Works & Activities

  • Journal Articles
    Deo, S., H. Tyagi, C. Chatterjee, H. Molakapuri. 2019. Did India's price control policy for coronary stents create unintended consequences? Social Science & Medicine 246, 112737
  • Journal Articles
    H. Tyagi, M. Sabharwal, N. Dixit, A. Pal, S. Deo. 2020. Leveraging providers' preferences to customize instructional content: A retrospective analysis of a mobile phone-based intervention. JMIR mHealth and uHealth 8 (3), e15998
  • Conference Proceedings
    V Heitlage, JF Farley, R Shah, H Tyagi, D Stenehjem. 2022. EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share. Value in Health 25 (7), S460
  • Other
    AC Powell, H Tyagi, JK Ludher. 2018. Digitising Indian healthcare records. Healthcare cover story, ISBInsight

Edit This Page

Edit Profile